BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+31.6%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$1.84B
AUM Growth
+$1.84B
(+32%)
Cap. Flow
+$76.3M
Cap. Flow
% of AUM
4.15%
Top 10 Holdings %
Top 10 Hldgs %
79.12%
Holding
28
New
5
Increased
6
Reduced
9
Closed
4
Top Buys
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$55.2M |
| 2 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$41.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$31.9M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$23.2M |
| 5 |
Neurocrine Biosciences
NBIX
|
$22.1M |
Top Sells
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$25.8M |
| 2 |
CELG
Celgene Corp
CELG
|
$23.3M |
| 3 |
Incyte
INCY
|
$22.7M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$21.3M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$9.92M |
Sector Composition
| 1 | Healthcare | 86.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $308M | 16.77% | 1,999,271 -150,915 | -7% | -$23.3M |
|
|
2
Ionis Pharmaceuticals
IONS
$6.79B
| $270M | 14.71% | 7,202,585 -566,587 | -7% | -$21.3M |
|
3
Gilead Sciences
GILD
$140B
| $228M | 12.41% | 3,627,714 -72,286 | -2% | -$4.54M |
|
|
4
Incyte
INCY
$16.5B
| $182M | 9.89% | 4,763,270 -593,879 | -11% | -$22.7M |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $106M | 5.79% | 1,404,445 | – | – |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $88M | 4.79% | 757,428 -20,698 | -3% | -$2.4M |
|
|
MDVN
7
DELISTED
MEDIVATION, INC.
MDVN
| $86.9M | 4.73% | 1,449,706 | – | – |
|
|
ARIA
8
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $67.9M | 3.69% | 3,689,071 +573,700 | +18% | +$10.6M |
|
9
Halozyme
HALO
$8.56B
| $60.9M | 3.31% | 5,516,322 -130,197 | -2% | -$1.44M |
|
|
IMGN
10
DELISTED
Immunogen Inc
IMGN
| $55.8M | 3.03% | 3,275,816 +13,722 | +0.4% | +$234K |
|
|
PCYC
11
DELISTED
PHARMACYCLICS INC
PCYC
| $55.2M | 3% | +399,030 | New | +$55.2M |
|
|
GEVA
12
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $45.3M | 2.46% | 714,602 +661,053 | +1,234% | +$41.9M |
|
|
ONXX
13
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $42.4M | 2.31% | 339,870 -206,630 | -38% | -$25.8M |
|
14
Innoviva
INVA
$1.29B
| $36.3M | 1.98% | 888,244 | – | – |
|
|
15
Regeneron Pharmaceuticals
REGN
$61.5B
| $31.9M | 1.74% | +102,000 | New | +$31.9M |
|
|
ECYT
16
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $30.3M | 1.65% | 2,269,345 -70,000 | -3% | -$933K |
|
17
Alnylam Pharmaceuticals
ALNY
$58.5B
| $30.2M | 1.64% | 471,288 +16,488 | +4% | +$1.06M |
|
|
CLVS
18
DELISTED
Clovis Oncology, Inc.
CLVS
| $23.2M | 1.26% | +381,886 | New | +$23.2M |
|
|
INFI
19
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $22.7M | 1.23% | 1,300,737 +210,909 | +19% | +$3.68M |
|
|
20
Neurocrine Biosciences
NBIX
$13.8B
| $22.1M | 1.2% | +1,950,148 | New | +$22.1M |
|
|
OPTR
21
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| $17.9M | 0.97% | 1,422,200 -24,500 | -2% | -$308K |
|
|
TSRO
22
DELISTED
TESARO, Inc.
TSRO
| $14.5M | 0.79% | +373,300 | New | +$14.5M |
|
|
IDIX
23
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $6.49M | 0.35% | 1,250,000 | – | – |
|
|
ACHN
24
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $5.37M | 0.29% | 1,779,340 +100,000 | +6% | +$302K |
|
|
25
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – | -178,028 | Closed | -$9.92M |
|